Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

Key Points The quality of evidence pertaining to the risk of recurrent thrombosis among patients with an antiphospholipid antibody is very low. Additional studies are needed to define the impact of APLA testing on clinical decision-making.

authors

Garcia, David
Akl, Elie
Carr, Richard
Kearon, Clive

status

published

publication date

2013

has subject area

1102 Cardiorespiratory Medicine and Haematology (FoR)
1103 Clinical Sciences (FoR)
1114 Paediatrics and Reproductive Medicine (FoR)
Algorithms (MeSH)
Animals (MeSH)
Antibodies, Antiphospholipid (MeSH)
Cohort Studies (MeSH)
Follow-Up Studies (MeSH)
Humans (MeSH)
Immunology (Science Metrix)
Recurrence (MeSH)
Risk Factors (MeSH)
Venous Thromboembolism (MeSH)

published in

Blood Journal